EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Antiangiogenic Activity of 4–Chloro–Phenyl–Carbothioamide Derivatives In Ex Vivo‏ ‏and In Vitro Experimental Study

Zainab M Ali, Haitham ‎Mahmood Kadhim‎, Omeed M. Hassan‎, Ammar Kubba‎, Zeena Ayad Hussein

Indonesian Journal of Pharmacy · 02.03.2026 · 145-156

DOI: 10.22146/ijp.16909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Pharmacy, online erschienen am 02.03.2026. Verfasst von Zainab M Ali und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis is a crucial and critical ‎process in growth and development ‎that ‎has received ‎study attention in recent decades.‎ Angiogenesis inhibitors are one of the cornerstones of modern ‎anticancer treatments, tumour develop resistance to drugs rapidly, thus providing new agents is ‎crucial for patient’s survival.‎ The study investigated the effect of different concentrations of the novel ‎4–chloro–phenyl–‎carbothioamide derivative using different angiogenesis assays.‎ The present study examined the potential antiangiogenic, antioxidant, and ‎cytotoxic properties of a carbothioamide indole derivative and assessed VEGF gene expression.‎ The tested indole derivative's antiangiogenic efficacy was assessed using the ex-vivo rat ‎aorta ring (RAR) assay. The DPPH test for scavenging activity was utilized to clarify the most ‎likely cause of its antiangiogenic action. The MTT assay assessed the proliferation of the HUVEC ‎cell line while the expression of the VEGF gene in the colon cancer (HCT116) cell line was ‎analysed.‎ The evaluated drug exhibited antiangiogenic efficacy with an IC50 value of 17.99µg/ml in ‎the RAR assay. The drug successfully reduced the DPPH free radical in a concentration-dependent ‎manner (IC50 = 100.30 µg/ml). The evaluated drug exhibited negligible to non-toxic effects on the ‎HUVEC cell line, with an IC50 value of 733.60 μg/ml. It significantly downregulates the VEGF ‎gene expression in HCT116 cells at 400 µg/ml.‎ In conclusion, the 2-NHC compound exhibited significant antioxidant and anti-angiogenesis ‎effects with minimum toxicity against normal human cells. 2-NHC appears to downregulate the ‎VEGF gene expression in colon cancer cell lines.

Zitieren

APA

Ali, Z. M., Kadhim‎, H. M., Hassan‎, O. M., Kubba‎, A., & Hussein, Z. A. (2026). Antiangiogenic Activity of 4–Chloro–Phenyl–Carbothioamide Derivatives In Ex Vivo‏ ‏and In Vitro Experimental Study. Indonesian Journal of Pharmacy, 145-156. https://doi.org/10.22146/ijp.16909

Vancouver

Ali ZM, Kadhim‎ HM, Hassan‎ OM, Kubba‎ A, Hussein ZA. Antiangiogenic Activity of 4–Chloro–Phenyl–Carbothioamide Derivatives In Ex Vivo‏ ‏and In Vitro Experimental Study. Indonesian Journal of Pharmacy. 2026:145-156. doi:10.22146/ijp.16909

BibTeX
@article{Ali2026,
  author = {Ali, Zainab M and Kadhim‎, Haitham ‎Mahmood and Hassan‎, Omeed M. and Kubba‎, Ammar and Hussein, Zeena Ayad},
  title = {Antiangiogenic Activity of 4–Chloro–Phenyl–Carbothioamide Derivatives In Ex Vivo‏ ‏and In Vitro Experimental Study},
  journal = {Indonesian Journal of Pharmacy},
  year = {2026},
  pages = {145--156},
  doi = {10.22146/ijp.16909}
}
Kostenlos starten →